RCM
ALBO

Rotella Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Rotella Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-607
Closed -$19K – 688
2015
Q2 		$19K Buy
+607
New +$20.4K 0.02% 416
2015
Q1 		– Sell
-417
Closed -$17K – 631
2014
Q4 		$17K Sell
417
-557
-57% -$24.5K 0.01% 349
2014
Q3 		$49K Buy
974
+231
+31% +$13.3K 0.05% 246
2014
Q2 		$48K Sell
743
-334
-31% -$23.2K 0.04% 307
2014
Q1 		$88K Buy
+1,077
New +$98K 0.11% 114

Other funds holding ALBO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rotella Capital Management's ALBO Position: Q3 2015 in Review

Rotella Capital Management sold out of Albireo Pharma Inc (ALBO) in Q3 2015, closing a stake of 607 shares — an estimated $19K sold.

Rotella Capital Management first reported a position in ALBO in Q1 2014 and held it in 5 quarters. The position peaked at $88K in Q1 2014. 38 funds tracked by Wall St. Rank hold ALBO as of Q3 2015.

  • Rotella Capital Management reported no remaining Albireo Pharma Inc position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 607 Albireo Pharma Inc shares in Q3 2015, an estimated $19K.
  • Rotella Capital Management first reported a position in Albireo Pharma Inc in Q1 2014 and held it in 5 quarters.
  • Rotella Capital Management's Albireo Pharma Inc position peaked at $88K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.